Gastrointestinal Diseases  >>  dexlansoprazole  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexlansoprazole / Generic mfg.
Dexilant, NCT01637571: Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain

Withdrawn
4
0
US
Dexilant, Dexilant Placebo, Dexlansoprazole
University of Iowa
Chest Pain, Gastrointestinal Reflux Disease
 
 
NCT01093755: Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Completed
4
30
US
dexlansoprazole, Dexilant, Omeprazole, Prilosec
Mayo Clinic
Inflammation, Barrett's Esophagus
11/14
11/14
NCT02351960: Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

Completed
4
296
RoW
Dexlansoprazole
Takeda
Gastroesophageal Reflux Disease
06/16
07/16

Download Options